A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole
Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescr...
Saved in:
Main Authors: | Mohsin Hamid (Author), Bilal Lashari (Author), Irfan Ahsan (Author), Ida Micaily (Author), Usman Sarwar (Author), Joseph Crocetti (Author) |
---|---|
Format: | Book |
Published: |
Greater Baltimore Medical Center,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer
by: Mohsin Hamid, et al.
Published: (2018) -
A Case of Actinomycetoma Treated with Trimethoprim + Sulfamethoxazole
by: Subekcha Karki, et al.
Published: (2015) -
Acute vesiculobullous eruption in lupus patient on trimethoprim-sulfamethoxazole
by: Michaela Rechdan, BS, et al.
Published: (2024) -
Analysis of the mechanisms of trimethoprim/sulfamethoxazole resistance in Staphylococcus aureus
by: T. Sato, et al.
Published: (2020) -
L'association sulfamethoxazole-trimethoprime en pathologie infectieuse
by: J. Lacoste, et al.
Published: (1976)